Sign Up Today and Learn More About Maze Therapeutics Stock
Invest in or calculate the value of your shares in Maze Therapeutics or other pre-IPO companies through EquityZen's platform.
Maze Therapeutics Stock (MAZT)
Maze Therapeutics is a biotechnology company that develops precision medicines for renal, cardiovascular, and metabolic diseases.
About Maze Therapeutics Stock
Founded
2018
Headquarters
South San Francisco, CA, US
Industries
Science and Engineering, Health Care, Biotechnology
Maze Therapeutics Press Mentions
Stay in the know about the latest news on Maze Therapeutics
Stealth biotech bags rights to VelaVigo bispecific in $440M deal
fiercebiotech • Apr 19, 2025
Why Argenx Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket
benzinga • Apr 11, 2025
Booz Allen Hamilton, Movado Group And Other Big Stocks Moving Lower In Friday's Pre-Market Session
benzinga • Apr 11, 2025
Why Chanson International Holding Shares Are Trading Higher By Around 170%; Here Are 20 Stocks Moving Premarket
benzinga • Apr 07, 2025
North America Startup Investment Spiked In Q1 Due To OpenAI, But Seed And Early Stage Fell
news • Apr 07, 2025
Maze Therapeutics Management
Leadership team at Maze Therapeutics
Board Member
Charles Homcy
Board Member
Vineeta Agarwala
Join now and verify your accreditation status to gain access to:
- Maze Therapeutics Current Valuation
- Maze Therapeutics Stock Price
- Maze Therapeutics Management
- Available deals in Maze Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Maze Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Maze Therapeutics Revenue and Financials
- Maze Therapeutics Highlights
- Maze Therapeutics Business Model
- Maze Therapeutics Risk Factors
- Maze Therapeutics Research Report from SACRA Research
Trading Maze Therapeutics Stock
How to invest in Maze Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Maze Therapeutics through EquityZen funds. These investments are made available by existing Maze Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Maze Therapeutics stock?
Shareholders can sell their Maze Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
